Skip header and navigation

Refine By

7 records – page 1 of 1.

[Child health services, school health services and day care centers. Coordinated health check-ups of 6-year-old children make the planning of school supportive measures easier]

https://arctichealth.org/en/permalink/ahliterature38410
Source
Lakartidningen. 1988 Sep 14;85(37):2946-7, 2950-1
Publication Type
Article
Date
Sep-14-1988

[Diagnosis and treatment of heart failure in primary health care. Low correlation between Pro-ANF and heart failure]

https://arctichealth.org/en/permalink/ahliterature54127
Source
Lakartidningen. 2000 Jan 19;97(3):159-62
Publication Type
Article
Date
Jan-19-2000
Author
K. Blomqvist
K. Ortoft
A. Johansson
S. Ascione
E. Nylander
I. Akerlind
Author Affiliation
Allmänmedicin, Aby vårdcentral, Linköping. Kjell.Blomqvist@aby.lin.lio.se
Source
Lakartidningen. 2000 Jan 19;97(3):159-62
Date
Jan-19-2000
Language
Swedish
Publication Type
Article
Keywords
Aged
Angiotensin-Converting Enzyme Inhibitors - administration & dosage
Atrial Natriuretic Factor - metabolism
English Abstract
Follow-Up Studies
Heart Failure, Congestive - diagnosis - drug therapy - metabolism - ultrasonography
Humans
Primary Health Care
Sweden
Abstract
Three eastern Swedish primary care clinics serving a predominantly rural clientele monitored for 13 months all patients under 80 years of age with a diagnosis based on clinical signs alone of heart failure (n = 56) or suspected incipient heart failure (n = 62). Echocardiography was performed on all patients. For 64% of the former group, the putative diagnosis matched echocardiography findings. Results showed a purely diastolic disorder in one-fifth of all 118 patients, and a hemodynamically significant, hitherto unknown heart defect in about as many. Pro-ANF assays correlated poorly with manifest heart failure. Pharmacological treatments were registered, and at 6-month follow-up, 82% of patients with systolic failure were receiving ACE-inhibition.
PubMed ID
10687345 View in PubMed
Less detail

[Functional evaluation of heart failure patients in primary care. The NYHA system is unreliable since intercurrent illness can give rise to similar symptoms]

https://arctichealth.org/en/permalink/ahliterature49875
Source
Lakartidningen. 2001 May 30;98(22):2713-7
Publication Type
Article
Date
May-30-2001
Author
K. Blomqvist
K. Ortoft
I. Akerlind
Author Affiliation
ST-läkare allmänmedicin, Aby vårdcentral.
Source
Lakartidningen. 2001 May 30;98(22):2713-7
Date
May-30-2001
Language
Swedish
Publication Type
Article
Keywords
Aged
Echocardiography
English Abstract
Exercise
Female
Heart Failure, Congestive - classification - complications - diagnosis - physiopathology
Humans
Male
Primary Health Care
Severity of Illness Index
Sweden
Abstract
A group of 158 patients with congestive heart failure was studied in detail concerning other types of morbidity. The purpose was to evaluate how often classification according to the NYHA system was disturbed by intercurrent disease with a similar set of symptoms. At the same time, a visual analogue scale for the evaluation of physical capacity was tested. Seventy-eight per cent of the patients had intercurrent disease putting them at risk of inadequate NYHA classification. There was no correlation between the patients' NYHA class and grade or type of echocardiographic ventricular dysfunction. However there was a correlation between NYHA class and the presence of intercurrent disease.
PubMed ID
11430229 View in PubMed
Less detail

Quality of life in 6497 Nordic patients with psoriasis.

https://arctichealth.org/en/permalink/ahliterature189727
Source
Br J Dermatol. 2002 Jun;146(6):1006-16
Publication Type
Article
Date
Jun-2002
Author
R. Zachariae
H. Zachariae
K. Blomqvist
S. Davidsson
L. Molin
C. Mørk
B. Sigurgeirsson
Author Affiliation
Psycho-oncology Research Unit, Aarhus University Hospital, Aarhus, Denmark. bzach@aaa.dk
Source
Br J Dermatol. 2002 Jun;146(6):1006-16
Date
Jun-2002
Language
English
Publication Type
Article
Keywords
Adult
Aged
Female
Humans
Male
Middle Aged
Psoriasis - epidemiology - psychology
Quality of Life
Questionnaires
Scandinavia - epidemiology
Severity of Illness Index
Stress, Psychological - epidemiology - etiology
Abstract
Disease-specific psoriasis-related quality of life (QOL) measures have recently been developed and used in several hospital-based investigations. However, little is known about the impact of psoriasis on QOL in people with psoriasis who are not referred by dermatologists.
The purpose of the study was to investigate psoriasis-related QOL in a large sample of members of the psoriasis associations from the Nordic countries, and to compare the results with those from psoriasis patients recruited from Nordic dermatologists or Nordic University clinics.
A total of 5795 association members and 702 patients rated their psoriasis severity and completed the Psoriasis Disability Index and the Psoriasis Life Stress Index.
Patients reported greater disease severity and greater impairment of QOL than members of associations, and Norwegian participants reported greater disease severity and greater impairment of QOL than participants from the remaining Nordic countries. Older and married participants reported less impairment of QOL than younger participants and those living alone. When controlling for the influence of these and other demographic and socio-economic factors, self-reported severity emerged as the most significant predictor of psoriasis-related QOL, explaining 32-26% of the variation in QOL scores, with the remaining factors only accounting for 4-5% of the variation. Although correlated with self-reported severity, Psoriasis Area and Severity Index scores were not a significant predictor of QOL in the patient sample.
Though self-reported severity may be the most important predictor, further research is needed to determine factors explaining the remaining variance in psoriasis-related QOL.
PubMed ID
12072069 View in PubMed
Less detail

Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers.

https://arctichealth.org/en/permalink/ahliterature69037
Source
J Eur Acad Dermatol Venereol. 2004 Jan;18(1):27-36
Publication Type
Article
Date
Jan-2004
Author
R. Zachariae
H. Zachariae
K. Blomqvist
S. Davidsson
L. Molin
C. Mørk
B. Sigurgeirsson
Author Affiliation
Psychooncology Research Unit, Aarhus University Hospital, Denmark. bzach@akh.aaa.dk
Source
J Eur Acad Dermatol Venereol. 2004 Jan;18(1):27-36
Date
Jan-2004
Language
English
Publication Type
Article
Keywords
Analysis of Variance
Chi-Square Distribution
Female
Humans
Logistic Models
Male
Middle Aged
Psoriasis - epidemiology - psychology
Quality of Life
Questionnaires
Research Support, Non-U.S. Gov't
Scandinavia - epidemiology
Severity of Illness Index
Stress, Psychological - epidemiology - psychology
Abstract
OBJECTIVES: The purpose of the study was to investigate the perceived influence of stress on psoriasis onset and disease severity in a large sample of psoriatics and to compare stress reactors and non-reactors with respect to psoriasis-related stress, disease severity, family history of psoriasis and sociodemographic factors. PATIENTS/METHODS: A total of 5795 members of the Nordic psoriasis associations and 702 patients recruited from Nordic dermatologists or university clinics were asked whether their first outbreak of psoriasis occurred during times of worry and stress. They were also asked to rate the degree to which their psoriasis was influenced by stress and to complete the Psoriasis Life Stress Index, the Psoriasis Disability Index and a number of additional questions concerning sociodemographic factors. RESULTS: Seventy-one per cent of the members and 66% of the patients reported that their psoriasis was exacerbated by stress, and 35% in both groups reported that the onset of their psoriasis occurred during a time of worry and stress. Stress reactors, scoring above the median on stress reactivity, reported greater disease severity, psoriasis-related stress and impairment of disease-related quality of life. They also reported more frequent use of tobacco, tranquillizers and antidepressants. More women than men were stress reactors, and stress reactors were more likely to have a family history of psoriasis. CONCLUSION: Our findings confirm and extend the results of previous studies and indicate that a subgroup of psoriatics may be more psychologically reactive to their disease and its influence on everyday life. Whether this group is also physiologically more reactive to psychosocial stress remains to be investigated.
PubMed ID
14678528 View in PubMed
Less detail

[Simplified ambulatory treatment of thrombosis. A daily dosage of subcutaneous low-molecular-weight heparin].

https://arctichealth.org/en/permalink/ahliterature214530
Source
Lakartidningen. 1995 Aug 23;92(34):3011-3
Publication Type
Article
Date
Aug-23-1995
Author
C. Hallert
K. Blomqvist
Author Affiliation
Medicinkliniken, Lasarettet i Norrköping.
Source
Lakartidningen. 1995 Aug 23;92(34):3011-3
Date
Aug-23-1995
Language
Swedish
Publication Type
Article
Keywords
Adult
Aged
Ambulatory Care
Follow-Up Studies
Heparin, Low-Molecular-Weight - administration & dosage - adverse effects
Humans
Middle Aged
Sweden
Thrombolytic Therapy - economics - methods
Thrombophlebitis - drug therapy
Abstract
Of 162 patients aged 27-28 years, referred during a 12-month period to the Dept. of medicine, Norrköping Central Hospital, for deep vein thrombosis (DVT), 102 (63 per cent) were treated as out-patients with the low molecular weight heparin preparation, dalteparin (Fragmin), given subcutaneously at a standardised daily dosage of 200 U/kg. No serious thrombotic events were reported. The frequency of post-thrombotic symptoms at six months did not differ from that among hospitalised patients on standard heparin treatment. Thus, the proportion of DVT patients treated as in-patients was reduced by 50 per cent, despite a 33 per cent increase in the number of referrals for DVT during the period. At follow-up, almost 90 per cent of the patients expressed satisfaction with the out-patient routines.
PubMed ID
7650990 View in PubMed
Less detail

Treatment of psoriasis in the Nordic countries: a questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life Study.

https://arctichealth.org/en/permalink/ahliterature71882
Source
Acta Derm Venereol. 2001 May;81(2):116-21
Publication Type
Article
Date
May-2001
Author
H. Zachariae
R. Zachariae
K. Blomqvist
S. Davidsson
L. Molin
C. Mørk
B. Sigurgeirsson
Author Affiliation
Department of Dermatology, Aarhus University Hospital, Denmark.
Source
Acta Derm Venereol. 2001 May;81(2):116-21
Date
May-2001
Language
English
Publication Type
Article
Keywords
Administration, Topical
Analysis of Variance
Anthralin - therapeutic use
Anti-Inflammatory Agents - therapeutic use
Calcitriol - analogs & derivatives - therapeutic use
Complementary Therapies
Cyclosporine - therapeutic use
Dermatologic Agents - therapeutic use
Europe
Female
Health Care Surveys - methods
Humans
Male
Methotrexate - therapeutic use
Middle Aged
PUVA Therapy - methods
Psoriasis - drug therapy - radiotherapy - therapy
Questionnaires
Research Support, Non-U.S. Gov't
Steroids - therapeutic use
Abstract
The data from a questionnaire-based study of 5,739 members of the psoriasis associations of Denmark, Finland, Iceland, Norway, Sweden and the Faeroe Islands showed that the two most commonly used active agents were topical steroids (89.7% total use and 49.4% present use) and calcipotriol (73.1% total use and 35.8% present use), with only small variations between the countries. Marked differences between the countries were, however, found within all other types of psoriasis therapy, including the so-called alternative treatments. Significant priorities varied between the different countries. The use of dithranol in Finland was almost twice the average. While 14.2% of Danish members had received grenz-rays within the last week only 0.1% of the Finns had been given the same treatment. Psoralen plus ultraviolet A (PUVA) was being used by 13.1% of the Finnish psoriatics compared with 3.8% of Danes, while PUVA was almost non-existent on the Faeroe Islands. The use of non-PUVA phototherapy was highest in Norway and Sweden. Almost 10% of the Danes were presently on methotrexate, which was used far more than etretinate/acitretin or cyclosporine. In contrast, Finnish patients more often received etretinate than other systemic agents, and in Iceland there was a higher present use of cyclosporine than of etretinate. The popularity of alternative therapies was highest in Iceland, where 26.6% had taken such medication during the last week. The results of the study suggest that different treatment patterns should be taken into consideration when discussing the prognosis of psoriasis in different countries.
PubMed ID
11501648 View in PubMed
Less detail

7 records – page 1 of 1.